1 October 2026
Three new commercial appointments for Symbiosis to drive international growth
We’re delighted to announce that we’ve further strengthened the Symbiosis commercial team with three new appointments. Payal Roychoudhury and Joaquín...
2 September 2026
Jos Vergeest Appointed at Symbiosis, Bringing Three Decades of Pharmaceutical Experience
We’re thrilled to announce the appointment of Jos Vergeest as Senior Business Development Director, bringing three decades of commercial pharmaceutical...
27 August 2026
Symbiosis Strengthens Commercial Team with Appointment of Jay Chima
We’re delighted to welcome Jay Chima to the Symbiosis team as Vice President, Business Development. The growing demand for biologics,...
21 June 2026
Biopharma Vital Signs – Interview with The Medicine Maker
As part of their coverage of Bio International 2026 in Boston, Symbiosis Commercial and Strategic Projects Director Alison Clayton was...
31 May 2026
Symbiosis in the Spotlight: BioPharma Boardroom Interview
Our Chief Operating Officer, David McClelland, recently sat down with BioPharma Boardroom to discuss how Symbiosis is strategically scaling to...
30 April 2026
CPHI Online – An Interview with Joanne Anderson
CPHI Online, the global community for the pharmaceutical industry, recently spoke with Symbiosis Chief Commercial Officer Joanne Anderson, to get...
31 March 2026
Symbiosis Expands Commercial Capabilities with Addition of New Stability Chamber
Symbiosis has expanded its Quality Control (QC) laboratory with the installation of a new 30°C stability chamber. This addition enables...
27 February 2026
Symbiosis Appoints Joanne Anderson as Chief Commercial Officer
Symbiosis is delighted to announce the appointment of Joanne Anderson as our Chief Commercial Officer (CCO). With over 25 years...
30 January 2026
International Day of Woman and Girls in Science 2026
International Day of Woman and Girls in Science is an initiative launched by the United Nations in 2015 to recognise...
19 December 2025
Symbiosis Begins Commercial Production at FDA-inspected Manufacturing Facility
Symbiosis has manufactured their first 10,000 vial batch at the company’s new facility in Stirling, UK. The project, delivered for...
26 November 2025
Symbiosis Formally Presented with Prestigious King’s Award by Lord-Lieutenant of Stirling and Falkirk
Symbiosis is delighted to have been formally presented with a 2025 King’s Award for Enterprise in the International Trade category,...
30 September 2025
Symbiosis Expands Sterile Manufacturing Capacity with Fill/Finish Line Qualification
Symbiosis has successfully completed qualification of its new FPD 50 Flexicon automated fill/finish line at its new commercial production facility...